Sign In
Buy HALO
$82.54
-0.760 (-0.91%)
At Close: Jul 31, 2026
Cleantek Industries Secures Significant International HALO SE Crown Mount Contract
10:33am, Thursday, 22'nd Jan 2026
Calgary, Alberta--(Newsfile Corp. - January 22, 2026) - Cleantek Industries Inc. (TSXV: CTEK) ("Cleantek" or the "Company"), an innovative provider of patented clean technology solutions that reduce b
Halozyme to Host Investor Conference Call to Provide Updated Financial Guidance and Business Update
04:05pm, Tuesday, 20'th Jan 2026
SAN DIEGO, Jan. 20, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced it will host an Investor Conference Call on Wednesday, January 28, 2026, at 5:30 am PT
Halozyme Therapeutics: A 6.3 Rating and a Future Full of Uncertainty
07:00pm, Monday, 19'th Jan 2026
Explore the exciting world of Halozyme Therapeutics (HALO 0.85%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into
Halozyme Therapeutics (HALO) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Tuesday, 13'th Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HALO or AXSM: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 09'th Jan 2026
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Halozyme Therapeutics (HALO) and Axsome Therapeutics (AXSM). But which of these two stocks offers va
Cardinal Capital Management Purchases Shares of 17,768 Halozyme Therapeutics, Inc. $HALO
05:04am, Friday, 09'th Jan 2026
Cardinal Capital Management acquired a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ: HALO) during the third quarter, according to the company in its most recent Form 13F filing with t
Allspring Global Investments Holdings LLC Has $2.11 Million Stock Holdings in Halozyme Therapeutics, Inc. $HALO
03:02am, Friday, 09'th Jan 2026
Allspring Global Investments Holdings LLC lifted its position in shares of Halozyme Therapeutics, Inc. (NASDAQ: HALO) by 247.8% during the undefined quarter, according to its most recent filing with t
Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab with ENHANZE®
08:00am, Thursday, 08'th Jan 2026
Agreement provides Takeda with exclusive access to ENHANZE® drug delivery technology for vedolizumab SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced
Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: H
Arbor Investment Advisors LLC Invests $1.32 Million in Halozyme Therapeutics, Inc. $HALO
03:48am, Saturday, 03'rd Jan 2026
Arbor Investment Advisors LLC bought a new stake in Halozyme Therapeutics, Inc. (NASDAQ: HALO) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commi
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Rating of “Hold” by Brokerages
01:12am, Monday, 29'th Dec 2025
Halozyme Therapeutics, Inc. (NASDAQ: HALO - Get Free Report) has received an average rating of "Hold" from the fourteen brokerages that are presently covering the stock, MarketBeat.com reports. One re
Osaic Holdings Inc. Grows Stock Holdings in Halozyme Therapeutics, Inc. $HALO
05:13am, Saturday, 27'th Dec 2025
Osaic Holdings Inc. grew its holdings in Halozyme Therapeutics, Inc. (NASDAQ: HALO) by 80.9% during the second quarter, according to the company in its most recent filing with the Securities and Excha
Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock
10:41am, Friday, 19'th Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Market Today: CPI Cools; Micron Lifts AI Stocks (MU)
05:35pm, Thursday, 18'th Dec 2025
Guru Stock PicksCI Select Canadian Equity Fund has made the following transactions:Reduce in TSX: ABX by 9.95%Sold out in TSX:DOLAdd in TSX: KEY by 27.62%New posi
RYBREVANT FASPRO™ is approved across all indications of RYBREVANT® (amivantamab-vmjw) SAN DIEGO , Dec. 18, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced
